WaveMan
WaveMan · Company
FTRE · Fortrea Holdings Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

FTRE Fortrea (FTRE) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-medical laboratories · CIK 0001965040
Quote by TradingView
Form 144 · 10
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
146
13F, latest reported quarter
Conversions, 180 days
13
Codes C/M, not in net · $0 priced

What the filings say about FTRE

Insiders, 180 days
-$4.5M net sold
6 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-06-23
Planned sales (Form 144), 90 days
$4.4M
10 notices

Fortrea insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Fortrea Holdings Inc. insiders sold a net $4.5M of stock across 53 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Morais Mark A.
Chief Operating Officer
SELL
2026-09-10 SECtraded 2026-09-09
3,149
$53.1K
+37.4%
Context
  • 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Aug 19, 2026.
  • The trade is 3.8% of the 81,794 shares held after it.
  • 1 other insider sold within 30 days.
  • 146 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Operating Officer Morais Mark A. sold about $53.1K of FTRE on Sep 9, 2026; 1 other insider sold within 30 days and 146 funds added in the latest 13F quarter.
Russell Carrie Elizabeth
Interim CAO
SELL
2026-09-10 SECtraded 2026-09-09
246
$4.1K
+37.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 10.3% of the 2,384 shares held after it.
  • 1 other insider sold within 30 days.
  • 146 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Interim CAO Russell Carrie Elizabeth sold about $4.1K of FTRE on Sep 9, 2026; 1 other insider sold within 30 days and 146 funds added in the latest 13F quarter.
Morais Mark A.
Chief Operating Officer
SELL
2026-08-19 SEC
4,892
$89.0K
+29.9%
Context
  • 15 earlier Form 4 trades (code P or S) here by this insider (15 sales), the last on Jun 10, 2026.
  • The trade is 6.3% of the 77,786 shares held after it.
  • 3 other insiders sold within 30 days.
  • 146 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Operating Officer Morais Mark A. sold about $89.0K of FTRE on Aug 19, 2026; 3 other insiders sold within 30 days and 146 funds added in the latest 13F quarter.
Thakral Anshul
Chief Executive Officer
SELL
2026-08-07 SECtraded 2026-08-06
55,882
$1.0M
+24.4%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Aug 5, 2026.
  • The trade is 21.4% of the 260,915 shares held after it.
  • 2 other insiders sold within 30 days.
  • 146 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Thakral Anshul sold about $1.0M of FTRE on Aug 6, 2026, the largest insider sale at the company on our record; 2 other insiders sold within 30 days and 146 funds added in the latest 13F quarter.
Thakral Anshul
Chief Executive Officer
SELL
2026-08-07 SECtraded 2026-08-06
55,975
$1.0M
+24.4%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Aug 5, 2026.
  • The trade is 27.3% of the 204,940 shares held after it.
  • 2 other insiders sold within 30 days.
  • 146 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Thakral Anshul sold about $1.0M of FTRE on Aug 6, 2026, the largest insider sale at the company on our record; 2 other insiders sold within 30 days and 146 funds added in the latest 13F quarter.
53 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 48 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$4.5M over 180 days
-$4.3M over 90 days
below 56% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
146 funds bought in last quarter
more than 56% of Healthcare Services
Revenue
+1.0% year over year
below 74% of Healthcare Services
Margin
-36.2% net margin
below 82% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
13.4% of the float short (float per yahoo 2026-10-26) · 7.8 days to cover · settled 2026-09-30
more than 91% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch FTRE

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+124.6%12M
-16%+32%+81%+129%2025-102025-122026-022026-042026-062026-082026-10 2026-08-06 · Thakral Anshul sold $1.0M2026-08-06 · Thakral Anshul sold $1.0M2026-08-05 · Thakral Anshul sold $972.0K2026-08-05 · Thakral Anshul sold $941.1K2026-08-03 · SANDERS MACHELLE sold $174.7K2026-08-19 · Morais Mark A. sold $89.0K2026-06-10 · Morais Mark A. sold $78.6K2026-06-02 · Morais Mark A. sold $75.4K2026-06-02 · Mcconnell Jill G. sold $75.4K2026-09-09 · Morais Mark A. sold $53.1K2026-05-18 · Parks Robert sold $26.9K2026-03-10 · Mcconnell Jill G. sold $23.3K2026-03-10 · Mcconnell Jill G. sold $22.6K2026-03-10 · Morais Mark A. sold $21.2K2026-03-10 · Morais Mark A. sold $20.5K2026-03-16 · Morais Mark A. sold $16.6K2026-03-16 · Mcconnell Jill G. sold $16.6K2026-03-10 · Parks Robert sold $8.9K2026-03-10 · Parks Robert sold $8.6K2026-02-10 · Morais Mark A. sold $8.3K2026-02-10 · Morais Mark A. sold $8.0K2026-02-10 · Mcconnell Jill G. sold $6.2K2026-02-10 · Mcconnell Jill G. sold $6.0K2026-09-09 · Russell Carrie Elizabeth sold $4.1K2026-09-11 · Mcconnell Jill G. filed to sell $17.7K2026-09-10 · Mcconnell Jill G. filed to sell $17.7K2026-09-09 · Russell Carrie Elizabeth filed to sell $4.1K2026-09-09 · Mcconnell Jill G. filed to sell $17.7K2026-09-09 · Morais Mark A. filed to sell $53.0K2026-08-19 · Mcconnell Jill G. filed to sell $89.0K2026-08-19 · Morais Mark A. filed to sell $89.0K2026-08-06 · Thakral Anshul filed to sell $2.0M2026-08-05 · Thakral Anshul filed to sell $1.9M2026-08-03 · SANDERS MACHELLE filed to sell $174.7K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns FTRE: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
15,799,104 sh
$274.9M
GOLDMAN SACHS GROUP INC
8,414,011 sh
$146.4M
Sessa Capital IM, L.P.
4,593,550 sh
$79.9M
VANGUARD CAPITAL MANAGEMENT LLC
4,181,552 sh
$72.8M
VANGUARD PORTFOLIO MANAGEMENT LLC
3,816,627 sh
$66.4M

Congress trades in FTRE

STOCK Act disclosures, US House only, filed up to 45 days after the trade
James French Hill
Sold 2025-06-23 · disclosed 31 days later
$1,001 - $15,000
All stocks members of Congress are buying · Every member's trades

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

FTRE planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Mcconnell Jill G.
Filed 2026-09-11
$17.7K
Mcconnell Jill G.
Filed 2026-09-10
$17.7K
Russell Carrie Elizabeth
Filed 2026-09-09
$4.1K
Mcconnell Jill G.
Filed 2026-09-09
$17.7K
Morais Mark A.
Filed 2026-09-09
$53.0K

FTRE mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Lord Abbett Focused Small Cap Value Fund
$4.2M position · as of 2026-07-31
4.3%
BECK, MACK & OLIVER PARTNERS FUND
$2.0M position · as of 2026-06-30
2.6%
Small-Cap Value Series
$9.3M position · as of 2026-05-31
2.4%
NYLIM WMC Small Companies Fund
$7.6M position · as of 2026-07-31
2.2%
Brandes U.S. Small-Mid Cap Value ETF
$2.9M position · as of 2026-06-30
1.7%
Loomis Sayles Small Cap Growth Portfolio
$3.6M position · as of 2026-06-30
1.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.5M sold by insiders over 180 days, 146 funds added last quarter, $4.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX

FTRE financials

Revenue growth
+1.0%
XBRL, annual
Net margin
-36.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.7B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-3.3%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$196.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
2.01x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
0.22x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
-15.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-3.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-0.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$3.1B
market value at close 2026-10-23 on 2026-07-27 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
+8.7%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$2.7B$2.7B$3.1B$3.1B
Operating income-$872.6M-$161.9M$32.0M$187.1M
Net income-$989.0M-$329.0M-$25.0M$186.2M
EPS (diluted)-10.81-3.67-0.292.09
Operating cash flow$113.5M$262.8M$168.4M$82.7M
Cash$174.6M$118.5M$108.6M$112.0M
Long-term debt$1.0B$1.0B$1.6B$0
SEC XBRL, fiscal years, as known on 2026-10-27

FTRE Stock Sonar score 6/7 axes

Find similar shapesCompare

FTRE ranks highest on institutional and government (56th percentile) and profitability (42nd), and lowest on risk and compliance (20th), among Healthcare Services peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
42
Inputs
  • Return on equity-15.8% · 35 pct, sector of 70
  • Return on assets-3.2% · 47 pct, sector of 88
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-0.6% · 43 pct, sector of 68
Financial health
33
Inputs
  • Debt to equity2.01x · 13 pct, sector of 61
  • Cash flow to debt0.22x · 52 pct, sector of 66
Growth
33
Inputs
  • Revenue growth, YoY+1.0% · 26 pct, sector of 87
  • Backlog growth, YoY-0.7% · 40 pct, universe of 854
Insider conviction
21
Inputs
  • Net Form 4 buying (codes P and S), 180d-$4.5M · 43 pct, sector of 64
  • Insider buyers, 180d0 · 0 pct, sector of 64
Institutional and government
56
Inputs
  • Funds adding, latest quarter146 · 56 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
20
Inputs
  • Short interest, % of float+13.4% · 18 pct, sector of 95
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+17.0% · 21 pct, sector of 72
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

FTRE filings, in plain words

Are Fortrea insiders buying or selling FTRE?

In the 180 days to 2026-10-27, Fortrea insiders were net sellers, a net $4.5M across purchases and sales reported on Form 4, by 6 sellers.

Have members of Congress traded FTRE?

Yes, but not in the year to 2026-10-27; the latest on record is a sale by James French Hill dated 2025-06-23.

Are there planned insider sales of FTRE?

Yes. 10 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $4.4M of stock; the latest, by Mcconnell Jill G., was filed 2026-09-11.

Read the full summary

In the 180 days to 2026-10-27, Fortrea insiders were net sellers of FTRE, a net $4.5M across purchases and sales reported on Form 4 by 6 sellers. None of the 12 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in FTRE, none in the last year; the latest on record is a sale by James French Hill dated 2025-06-23. Insiders filed 10 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $4.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies